Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4

2(40.0%)

Phase 2

2(40.0%)

N/A

1(20.0%)

5Total

Phase 4(2)

Phase 2(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04263038Phase 4Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Role: collaborator

NCT04141501Phase 2Completed

Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients

Role: collaborator

NCT03715127Phase 2Completed

Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept

Role: collaborator

NCT02478905Completed

Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting

Role: collaborator

NCT01821664Unknown

Vascular Graft Infections

Role: collaborator

NCT00946816Not ApplicableCompleted

The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity

Role: collaborator

NCT00944593Phase 4Withdrawn

Gastric vs Jejunal Feeding in Diabetic Gastroparesis

Role: collaborator

All 7 trials loaded